Riken

A sheet of paper reading venture capital
Biotech

Lynk inks $50M series B for 3 early-stage trials

Lynk Pharmaceuticals has another $50 million bankroll phase 1 and 2 clinical trials of its myelofibrosis and inflammatory bowel disease candidates.
Kyle LaHucik Aug 27, 2021 9:55am
Bayer

Bayer forms drug discovery pact with Japan's Riken Innovation

Oct 9, 2019 8:25am
head and brain

Stroke treatment normalizes brain fluids, restores movement in mice

May 13, 2019 3:00pm